CAR T Therapy Beyond Cancer Enters Autoimmunity, Fibrosis, and Infection
A 2026 review examines how CAR T platforms are being adapted for HIV, autoimmunity, fibrosis, transplantation, hemophilia, and senescence.
Clinical evidence, research, and medical intelligence in Immunology.
Clinical evidence, research, and medical intelligence in Immunology.